Solana Company (HSDT)
NASDAQ: HSDT · Real-Time Price · USD
18.03
-0.13 (-0.72%)
At close: Oct 8, 2025, 4:00 PM EDT
18.34
+0.31 (1.72%)
After-hours: Oct 8, 2025, 6:55 PM EDT
Solana Company Revenue
Solana Company had revenue of $43.00K in the quarter ending June 30, 2025, a decrease of -76.37%. This brings the company's revenue in the last twelve months to $295.00K, down -50.34% year-over-year. In the year 2024, Solana Company had annual revenue of $520.00K, down -19.25%.
Revenue (ttm)
$295.00K
Revenue Growth
-50.34%
P/S Ratio
2.23
Revenue / Employee
$14,048
Employees
21
Market Cap
710.06M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 520.00K | -124.00K | -19.25% |
| Dec 31, 2023 | 644.00K | -143.00K | -18.17% |
| Dec 31, 2022 | 787.00K | 265.00K | 50.77% |
| Dec 31, 2021 | 522.00K | -139.00K | -21.03% |
| Dec 31, 2020 | 661.00K | -835.00K | -55.82% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 422.82B |
| Johnson & Johnson | 90.63B |
| Merck & Co. | 63.62B |
| AbbVie | 58.33B |
| AstraZeneca | 56.50B |
| Novartis AG | 55.19B |
| Eli Lilly and Company | 53.26B |
| Novo Nordisk | 49.11B |
HSDT News
- 9 days ago - Preeminent SOL Treasury Company Helius (NASDAQ:HSDT) Announces Corporate Name Change to Solana Company and Letter of Intent with Solana Foundation - GlobeNewsWire
- 13 days ago - Helius Announces FDA 510(k) Submission for PoNS® Device Label Expansion in Stroke - GlobeNewsWire
- 15 days ago - Helius Medical Stock Pops 8.5% After Hours On Solana Treasury Purchases - Benzinga
- 16 days ago - Helius (NASDAQ:HSDT) Begins Purchases of SOL, the Native Asset of Solana Blockchain - GlobeNewsWire
- 20 days ago - Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Closes Over $500 Million Private Placement to Launch SOL Treasury Company - PRNewsWire
- 23 days ago - Inside Helius Medical's $500 Million Raise — And Its Solana Treasury Plans - Benzinga
- 23 days ago - Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasury Company - PRNewsWire
- 2 months ago - Helius Announces Positive Outcome of the Portable Neuromodulation Stimulator PoNS® Stroke Registrational Program and Upcoming Submission to FDA Under Breakthrough Designation - GlobeNewsWire